RAIN

Rain Enhancement Technologies Holdco Inc (NASDAQ:RAIN) is a recently public company that went public on January 2, 2025, operating as a holding company focused on developing and commercializing ionization rainfall generation technology. The company represents a unique intersection of technology and environmental services, targeting industries, governments, and organizations that require additional rainfall for agricultural, industrial, or environmental purposes. Despite being a newly traded entity, the company appears to have undergone significant corporate changes, as evidenced by historical financial data showing it previously operated as Rain Oncology Inc., a clinical-stage oncology company that pivoted away from cancer drug development after failed trials.